Redcare Pharmacy slightly beats Q3 revenue estimates on German prescription sales
Dutch online pharmacy's third-quarter revenue rose 18% year on year, with strong prescription sales in Germany supporting growth, according to Reuters.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Dutch online pharmacy Redcare Pharmacy reported third-quarter revenue of 847 million euros, slightly above the 843.97 million euro average forecast of three analysts. According to Reuters, citing LSEG and company data, revenue grew 18% year on year, while adjusted EBITDA jumped 68%. The adjusted EBITDA margin rose 1.0 percentage point to 3.4%. Net income came in at 1 million euros.
The company links the growth to strong prescription sales in Germany and a widening customer base. It also said better profitability was partly due to lower marketing spending and a reduced cost per order.
For 2026, Redcare expects revenue growth of 16% to 18% and non-prescription revenue growth of 10% to 12%. It forecasts German prescription revenue of 730 million to 760 million euros.
why it matters
For markets the report is broadly neutral: revenue came in close to expectations, and cost cuts in marketing were the main driver of the margin gain. Analysts on average rate the shares a buy, but that is their view, not a forecast of price moves.
tags
instruments
sources
- Netherlands' Redcare Pharmacy slightly beats Q3 revenue estimates on strong prescription sales in Germany — Reuters, 29 October 2026 at 05:41 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗